United States · FDA National Drug Code directory
SPIRONOLACTONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0574-1133_902035fb-dba8-4fdf-9d8d-29d736c07d57
- Product NDC
- 0574-1133
- Form
- SUSPENSION
- Composition / generic term
- spironolactone
- Labeler
- Padagis US LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20231031
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 118 mL in 1 BOTTLE (0574-1133-04) · 0574-1133-04
- 10 CUP, UNIT-DOSE in 1 CARTON (0574-1133-10) / 5 mL in 1 CUP, UNIT-DOSE (0574-1133-05) · 0574-1133-10
- 473 mL in 1 BOTTLE (0574-1133-16) · 0574-1133-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →